Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959)

Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959)

Abstract Background In locoregionally advanced nasopharyngeal carcinoma (LANPC) patients, variance of tumor response to induction chemotherapy (ICT) was observed. We developed and validated a novel imaging biomarker to predict which patients will benefit most from additional ICT compared with chemor...

Full description

Bibliographic Details
Main Authors: Di Dong, Fan Zhang, Lian-Zhen Zhong, Meng-Jie Fang, Cheng-Long Huang, Ji-Jin Yao, Ying Sun, Jie Tian, Jun Ma, Ling-Long Tang
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Medicine
Subjects:
Individualized imaging biomarker
Induction chemotherapy
Survival benefit
Treatment decision
Locoregionally advanced nasopharyngeal cancer
Online Access:http://link.springer.com/article/10.1186/s12916-019-1422-6

Internet

http://link.springer.com/article/10.1186/s12916-019-1422-6

Similar Items